Treatment of tobacco dependence

Mayo Clinic Proceedings

Volumn 83, Issue 4, 2008, Pages 479-484

  Burke, Michael V ^a   Ebbert, Jon O ^a   Hays, J Taylor ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CORTICOSTEROID DERIVATIVE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NOSE SPRAY; PLACEBO; VARENICLINE;

AGGRESSIVENESS; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PRURITUS; APPLICATION SITE VESICLE; BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COUGHING; DIARRHEA; DISABILITY; DISEASE MODEL; DROWSINESS; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EYE IRRITATION; GINGIVA DISEASE; HEARTBURN; HICCUP; HUMAN; INDIGESTION; INHALER; INSOMNIA; LOZENGE; MOUTH DISEASE; NAUSEA; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; RECOMMENDED DRUG DOSE; RELAPSE; REMISSION; REVIEW; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SKIN IRRITATION; SKIN MANIFESTATION; SMOKING CESSATION; SUICIDAL IDEATION; THROAT IRRITATION; TOBACCO DEPENDENCE; TREATMENT DURATION; VIVID DREAM; XEROSTOMIA;

EID: 42149125472     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.4.479     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. State-specific prevalence of current cigarette smoking among adults and secondhand smoke rules and policies in homes and workplaces-United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55(42):1148-1151.
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238-1245.
3. American Cancer Society. Cancer Facts and Figures 2007. http://www.cancer.org. Accessed February 27, 2008.
4. Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res. 2004;6(suppl 3):S363-S369.
5. National Committee for Quality Assurance. http://web.ncqa.org. Accessed February 27, 2008.
6. Joint Commission. Performance Measurement Initiatives: Core Measure Set Information. http://www.jointcommission.org. Accessed February 27, 2008.
7. Fiore MC, Bailey WC, Cohen SJ, et al. Clinical Practice Guideline: Treating Tobacco Use and Dependence. Rockville, MD: US Dept of Health and Human Services, Public Health Service; 2000.
8. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99(1):29-38.
9. Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R. Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ. 2003;327(7405):28-29.
10. Fu SS, Partin MR, Snyder A, et al. Promoting repeat tobacco dependence treatment: are relapsed smokers interested? Am J Manag Care. 2006;12(4):235-243.
11. Joseph AM, Rice K, An LC, Mohiuddin A, Lando H. Recent quitters' interest in recycling and harm reduction. Nicotine Tob Res. 2004;6(6):1075-1077.
12. Bao Y, Duan N, Fox SA. Is some provider advice on smoking cessation better than no advice? an instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res. 2006;41(6):2114-2135.
13. Solberg LI, Boyle RG, Davidson G, Magnan SJ, Carlson CL. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clin Proc. 2001;76(2):138-143.
14. Cokkinides V, Bandi P, Ward E, Jemal A, Thun M. Progress and opportunities in tobacco control. CA Cancer J Clin. 2006;56(3):135-142.
15. Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract. 2000;49(9):796-804.
16. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med. 1995;24(1):41-47.
17. Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A. Nicotine nasal spray with nicotine patch for smoking cessation: randomized trial with six year follow up. BM. 1999;318(7179):285-288.
18. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340(9):685-691.
19. Croghan IT, Hurt RD, Dakhil SR, et al. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc. 2007;82(2):186-195.
20. Hurt RD, Dale LC, Croghan GA, Croghan IT, Gomez-Dahl LC, Offord KP. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Mayo Clin Proc. 1998; 73(2):118-125.
21. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007 Jan 24;1:CD000031.
22. Gonzales D, Rennard SI, Nides M, et al; Varenicline Phase 3 Study Group. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47-55.
23. Jorenby DE, Hays JT, Rigotti NA, et al; Varenicline Phase 3 Study Group. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial [published correction appears in JAMA. 2006; 296(11):1355]. JAMA. 2006;296(1):56-63.
24. Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J. 2003;24(10):946-955.
25. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006;6:300.
26. US Food and Drug Administration. FDA Alert: varenicline (marketed as Chantix) information. http://www.fda.gov/Cder/drug/infopage/varenicline/default. htm. Accessed March 11, 2008.
27. Swartz LH, Noell JW, Schroeder SW, Ary DV. A randomised control study of a fully automated internet based smoking cessation programme. Tob Control. 2006;15(1):7-12.
28. Pbert L. Healthcare provider training in tobacco treatment: building competency. Am J Med Sci. 2003;326(4):242-247.
29. Davis RM, Slade J, Ferry LH. Quality improvement and accountability in the treatment of tobacco dependence: the need for a national training and certification programme [editorial]. Tob Control. 2000;9(4):355-358.
30. North American Quitline Consortium. US Quitline Facts. http://www.naquitline.org. Accessed February 27, 2008.